@article{9aca177a867d42bca528b1d0229d6d72,
title = "Benefits of CMAB007 in Chinese Patients Having Inadequately Controlled Moderate/Severe Asthma With Increased Total IgE: A Randomized Phase 3 Trial",
keywords = "Asthma, IgE, antibody, asthma exacerbation, lung function, omalizumab, treatment outcome",
author = "Kefang Lai and Zhijun Yan and Donghua Qian and Xiaoju Zhang and Tao Bian and Xiaotian Dai and Huiping Li and Lin Lin and Jin Wang and Linwei Wang and Jingping Yang and Yaomin Hu and Hui Li and Xiuhong Nie and Faguang Jin and Guoxiang Li and Shenghua Sun and Feng Xu and Hui Zhao and Yusheng Chen and Chuntao Liu and Huili Zhu and Jing Li and Yajun Guo and Nanshan Zhong",
note = "Publisher Copyright: Copyright {\textcopyright} 2026 The Korean Academy of Asthma, Allergy and Clinical Immunology The Korean Academy of Pediatric Allergy and Respiratory Disease This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:// creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",
year = "2026",
month = jan,
doi = "10.4168/aair.2026.18.1.39",
language = "English",
volume = "18",
pages = "39--54",
journal = "Allergy, Asthma and Immunology Research",
issn = "2092-7355",
number = "1",
}